Federal Register of Legislation - Australian Government

Primary content

PB 53 of 2019 Determinations/Health as made
This instrument amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010) by determining that three drugs are delisting off the Pharmaceutical Benefits Scheme and are required to be removed from F1.
Administered by: Health
Registered 28 Jun 2019
Tabling HistoryDate
Tabled HR02-Jul-2019
Tabled Senate02-Jul-2019
Date of repeal 17 Sep 2019
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

 

PB 53 of 2019

 

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated               27 June 2019

 

 

 

 

 

 

 

 

 

THEA DANIEL

 

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

Part 1         Preliminary

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2019 (No. 6).

         (2)   This Determination may also be cited as PB 53 of 2019.

2              Commencement

                This Determination commences on 1 July 2019.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).


Schedule 1             Amendments

 

(Section 3)

 

[1]     Schedule 1, after item dealing with Abacavir

 

Omit

Abciximab

 

[2]     Schedule 1, after item dealing with Cyclophosphamide

 

Omit

Cystine with carbohydrate

 

[3]     Schedule 1, after item dealing with Pyridostigmine

 

Omit

Pyrimethamine